Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Pharmaceutical Labeling and Barcoding Services

Open
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79727R0010.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Nitroglycerin Patches

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs final packaging, labeling, and barcoding of Nitroglycerin patches for prime contractors on Department of Veterans Affairs and DoD supply contracts. Boxes patches in 30-unit quantities, applies barcodes to individual patches and outer boxes, and applies unique NDC labels per FDA regulations. Ensures label adhesion allows for VA over-labeling. Delivers retail-ready, barcoded, and labeled boxes of patches.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Nitroglycerin Patches
Solicitation # 36E79727R0010
The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.
Nac Pharmaceuticals (36E797)

POSTED

about 14 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
International
Calcium Trisodium Pentetate (Ca-DTPA) ampoules
Solicitation # W6369-27-A062
The Department of National Defence, through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, is seeking the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules to treat Canadian Armed Forces personnel exposed to radioactive contamination involving transuranic elements. The required product must be a sterile solution for intravenous injection containing 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule, with a minimum shelf-life of 36 months from the date of manufacture. To ensure consistency with existing stockpiles, the product must adhere to specific packaging and labelling requirements and hold valid marketing authorization from Health Canada, the FDA, the EMA, or an EU member state. The procurement is being conducted via an Advance Contract Award Notice, with Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG identified as the sole known supplier capable of meeting the technical and clinical requirements. The contract is anticipated to run from the award date until March 31, 2031, with an estimated total value of 47,500 CAD. The firm requirement consists of 750 ampoules delivered in three annual increments of 250, starting no later than March 1, 2027, and ending by March 1, 2029. Additionally, the contract includes an option for up to 500 more ampoules exercisable throughout the contract period. This procurement is subject to the Canadian Free Trade Agreement and is not subject to set-asides or the Procurement Strategy for Indigenous Business.
Department of National Defence

POSTED

about 21 hours ago

DEADLINE

in 15 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 7 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS